BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17312221)

  • 1. Hydroxyethyl starch, but not modified fluid gelatin, affects inflammatory response in a rat model of polymicrobial sepsis with capillary leakage.
    Feng X; Yan W; Wang Z; Liu J; Yu M; Zhu S; Xu J
    Anesth Analg; 2007 Mar; 104(3):624-30. PubMed ID: 17312221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of hydroxyethyl starch 130/0.4 in pulmonary neutrophil recruitment and acute lung injury during polymicrobial sepsis in rats.
    Feng X; Ren B; Xie W; Huang Z; Liu J; Guan R; Duan M; Xu J
    Acta Anaesthesiol Scand; 2006 Oct; 50(9):1081-8. PubMed ID: 16987337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hydroxyethyl starch 130/0.4 on pulmonary capillary leakage and cytokines production and NF-kappaB activation in CLP-induced sepsis in rats.
    Feng X; Yan W; Liu X; Duan M; Zhang X; Xu J
    J Surg Res; 2006 Sep; 135(1):129-36. PubMed ID: 16616763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the effect of hydroxyethyl starch on reducing pulmonary capillary permeability in a rat model of sepsis.
    Lv R; Zhou W; Chu C; Xu J
    Ann Clin Lab Sci; 2005; 35(2):174-83. PubMed ID: 15943182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early treatment with hydroxyethyl starch 130/0.4 causes greater inhibition of pulmonary capillary leakage and inflammatory response than treatment instituted later in sepsis induced by cecal ligation and puncture in rats.
    Feng X; Hu Y; Ding J; Ge Y; Song J; Ai Q; Zhang Z; Xu J
    Ann Clin Lab Sci; 2007; 37(1):49-56. PubMed ID: 17311869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective roles of hydroxyethyl starch 130/0.4 in intestinal inflammatory response and survival in rats challenged with polymicrobial sepsis.
    Feng X; Liu J; Yu M; Zhu S; Xu J
    Clin Chim Acta; 2007 Feb; 376(1-2):60-7. PubMed ID: 16942763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyethyl starch 130/0.4 prevents the early pulmonary inflammatory response and oxidative stress after hemorrhagic shock and resuscitation in rats.
    Wang P; Li Y; Li J
    Int Immunopharmacol; 2009 Mar; 9(3):347-53. PubMed ID: 19166983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyethyl starch inhibits NF-kappaB activation and prevents the expression of inflammatory mediators in endotoxic rats.
    Tian J; Lin X; Zhou W; Xu J
    Ann Clin Lab Sci; 2003; 33(4):451-8. PubMed ID: 14584760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyethyl starch exhibits antiinflammatory effects in the intestines of endotoxemic rats.
    Lv R; Zhou ZQ; Wu HW; Jin Y; Zhou W; Xu JG
    Anesth Analg; 2006 Jul; 103(1):149-55, table of contents. PubMed ID: 16790644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hydroxyethyl starch on lipopolysaccharide-induced tissue nuclear factor kappa B activation and systemic TNF-alpha expression.
    Tian J; Lin X; Li YH; Xu JG
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1311-7. PubMed ID: 16146468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyethyl starch 130/0.4 augments healing of colonic anastomosis in a rat model of peritonitis.
    Wang P; Gong G; Li Y; Li J
    Am J Surg; 2010 Feb; 199(2):232-9. PubMed ID: 19897171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyethyl starch 130/0.4 inhibits production of plasma proinflammatory cytokines and attenuates nuclear factor-kappaB activation and Toll-like receptors expression in monocytes during sepsis.
    Xie J; Lv R; Yu L; Huang W
    J Surg Res; 2010 May; 160(1):133-8. PubMed ID: 19766237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hydroxyethyl starch on hepatic production of cytokines and activation of transcription factors in lipopolysaccharide-administered rats.
    Lv R; Zhou W; Zhang LD; Xu JG
    Acta Anaesthesiol Scand; 2005 May; 49(5):635-42. PubMed ID: 15836676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats.
    Song XM; Li JG; Wang YL; Hu ZF; Zhou Q; Du ZH; Jia BH
    Shock; 2008 Oct; 30(4):468-72. PubMed ID: 18391858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low intensity laser therapy (LILT) in vivo acts on the neutrophils recruitment and chemokines/cytokines levels in a model of acute pulmonary inflammation induced by aerosol of lipopolysaccharide from Escherichia coli in rat.
    Mafra de Lima F; Villaverde AB; Salgado MA; Castro-Faria-Neto HC; Munin E; Albertini R; Aimbire F
    J Photochem Photobiol B; 2010 Dec; 101(3):271-8. PubMed ID: 20728373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of pulmonary inflammatory response by erythropoietin in a rat model of endotoxaemia.
    Shang Y; Jiang YX; Xu SP; Wu Y; Wu ZY; Yuan SY; Yao SL
    Chin Med J (Engl); 2009 Apr; 122(7):834-8. PubMed ID: 19493399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis.
    Sheehan M; Wong HR; Hake PW; Zingarelli B
    Crit Care Med; 2003 Sep; 31(9):2263-70. PubMed ID: 14501955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ketamine on levels of cytokines, NF-kappaB and TLRs in rat intestine during CLP-induced sepsis.
    Yu M; Shao D; Liu J; Zhu J; Zhang Z; Xu J
    Int Immunopharmacol; 2007 Aug; 7(8):1076-82. PubMed ID: 17570324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular mechanism of inhibition of early pulmonary injury and inflammatory response by exogenous carbon monoxide: experiment with mice].
    Sun BW; Chen X; Chen ZY; Katada K; Cepinskas G
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3148-51. PubMed ID: 18269877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of the anti-inflammatory effects of hydroxyethyl starch demonstrated in a flow-based model of neutrophil recruitment by endothelial cells.
    Matharu NM; Butler LM; Rainger GE; Gosling P; Vohra RK; Nash GB
    Crit Care Med; 2008 May; 36(5):1536-42. PubMed ID: 18434912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.